You're missing the point.
ZNO doesn't claim to be the only product to kill CORID-19.
ZNO isn't trying to corner the market in CORD-19 prevention which is worth billions of $.
There are other products that kill CORD-19, no one is denying this.
ZNO market cap is currently around $310m.
PE 35 = NPAT of $8.9m.
Margins around 67% for FY21, low overheads.
It doesn't take a huge amount of B2B sales to justify the share price when you're selling up to $50k a day with zero marketing or sales effort.
Add to My Watchlist
What is My Watchlist?
